S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
NASDAQ:NTEC

Intec Pharma SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
N/A
50-Day Range
$9.15
$36.20
52-Week Range
N/A
Volume
988,300 shs
Average Volume
543,436 shs
Market Capitalization
$8.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.83

Intec Pharma (NASDAQ:NTEC) SEC Filings

DateFilerForm TypeView
06/22/2021
7:59 AM
Intec Pharma (Subject)
Form 425
06/22/2021
7:57 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2021
6:00 AM
Intec Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2021
4:29 PM
Intec Parent Inc. (Filer)
Intec Pharma (Filer)
Form S-4/A
04/30/2021
3:30 PM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2021
3:30 PM
Intec Pharma (Subject)
Form 425
04/20/2021
4:31 PM
Intec Parent Inc. (Filer)
Intec Pharma (Filer)
Form S-4
Registration statement under Securities Act of 1933  
03/17/2021
3:28 PM
Intec Pharma (Filer)
Form 10-K/A
03/16/2021
4:27 PM
Intec Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/15/2021
7:40 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2021
7:38 AM
Intec Pharma (Subject)
Form 425
02/08/2021
6:00 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2021
5:09 AM
Intec Pharma (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SC 13G/A
01/04/2021
12:40 PM
Intec Pharma (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
12/09/2020
6:07 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
7:00 AM
Intec Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
6:11 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
6:42 AM
Intec Pharma (Subject)
MEITAV DASH INVESTMENTS LTD (Filed by)
Form SC 13G/A
10/29/2020
7:21 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2020
6:08 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2020
4:02 PM
Intec Pharma (Issuer)
Sassi Nir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2020
4:01 PM
Intec Pharma (Issuer)
Linscott Walt Addison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2020
4:00 PM
Intec Pharma (Issuer)
Navon Nadav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2020
3:30 PM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2020
3:31 PM
Intec Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/05/2020
6:08 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2020
3:39 PM
Intec Pharma (Issuer)
Pomerantz Roger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2020
3:38 PM
Intec Pharma (Issuer)
Meckler Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2020
3:34 PM
Intec Pharma (Issuer)
MADDALUNA ANTHONY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2020
3:33 PM
Intec Pharma (Issuer)
Karah Hila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2020
3:33 PM
Hayes William B (Reporting)
Intec Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2020
3:30 PM
Intec Pharma (Issuer)
KOZARICH JOHN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2020
3:30 PM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2020
11:15 PM
Intec Pharma (Filer)
Form EFFECT
06/08/2020
4:21 PM
Intec Pharma (Filer)
Form DEF 14A
06/08/2020
4:00 PM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2020
3:40 PM
ARMISTICE CAPITAL, LLC (Filed by)
Intec Pharma (Subject)
Form SC 13G
05/13/2020
10:52 AM
CVI Investments, Inc. (Filed by)
Intec Pharma (Subject)
Form SC 13G
05/11/2020
3:25 PM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
9:47 AM
Intec Pharma (Filer)
Form 424B5
05/06/2020
9:44 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2020
6:45 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2020
7:32 AM
Dexcel Pharma Technologies Ltd. (Filed by)
Intec Pharma (Subject)
Form SC 13G/A
02/19/2020
8:46 PM
Intec Pharma (Issuer)
Sassi Nir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
8:46 PM
Intec Pharma (Issuer)
Navon Nadav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
8:45 PM
Intec Pharma (Issuer)
Linscott Walt Addison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
8:45 PM
GENDREAU R MICHAEL (Reporting)
Intec Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
9:23 AM
Avoro Capital Advisors LLC (Filed by)
Intec Pharma (Subject)
Form SC 13G/A
02/12/2020
9:05 AM
Intec Pharma (Subject)
MEITAV DASH INVESTMENTS LTD (Filed by)
Form SC 13G/A
02/10/2020
7:50 PM
Intec Pharma (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SC 13G
02/07/2020
3:49 PM
ARMISTICE CAPITAL, LLC (Filed by)
Intec Pharma (Subject)
Form SC 13G
02/05/2020
2:10 PM
Intec Pharma (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G
02/04/2020
5:41 PM
Dexcel Pharma Technologies Ltd. (Reporting)
Intec Pharma (Issuer)
Oren Dan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2020
4:28 PM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2020
4:27 PM
Intec Pharma (Filer)
Form 424B5
01/30/2020
3:40 PM
Intec Pharma (Filer)
Form 424B5
12/11/2019
6:48 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2019
6:40 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2019
6:39 AM
Intec Pharma (Filer)
Form 424B5
12/02/2019
4:21 PM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2019
4:00 PM
Intec Pharma (Issuer)
Silberman Issac (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:18 PM
Intec Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
3:15 PM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2019
3:15 PM
Intec Pharma (Filer)
Form DEF 14A
10/07/2019
3:52 PM
Intec Pharma (Filer)
Form PRE 14A
09/27/2019
3:16 PM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
8:32 PM
Intec Pharma (Issuer)
Sassi Nir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
8:28 PM
Intec Pharma (Issuer)
Linscott Walt Addison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
7:08 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2019
7:01 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2019
3:17 PM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2019
3:16 PM
Intec Pharma (Issuer)
Meckler Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2019
3:16 PM
Intec Pharma (Issuer)
MADDALUNA ANTHONY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:20 PM
Intec Pharma (Issuer)
KOZARICH JOHN W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:18 PM
Intec Pharma (Issuer)
Meckler Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
6:17 AM
Intec Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
6:13 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2019
7:00 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2019
3:42 PM
Intec Pharma (Issuer)
Silberman Issac (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2019
6:01 AM
Intec Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
6:00 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2019
4:27 PM
Intec Pharma (Issuer)
Meckler Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2019
4:21 PM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2019
11:16 PM
Intec Pharma (Filer)
Form EFFECT
03/28/2019
4:06 PM
Intec Pharma (Filer)
Form 424B5
03/11/2019
2:35 PM
Intec Pharma (Filer)
Form CT ORDER
03/01/2019
3:16 PM
Intec Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/28/2019
4:16 PM
Intec Pharma (Filer)
Form DEF 14A
02/27/2019
6:13 AM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
7:56 AM
Dexcel Pharma Technologies Ltd. (Filed by)
Intec Pharma (Subject)
Form SC 13G/A
02/14/2019
7:52 AM
Dexcel Pharma Technologies Ltd. (Reporting)
Intec Pharma (Issuer)
Oren Dan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/14/2019
7:28 AM
Intec Pharma (Subject)
venBio Select Advisor LLC (Filed by)
Form SC 13G/A
02/13/2019
12:33 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Intec Pharma (Subject)
Form SC 13G/A
02/12/2019
3:34 PM
Intec Pharma (Filer)
Form PRE 14A
02/07/2019
6:37 AM
Intec Pharma (Subject)
MEITAV DASH INVESTMENTS LTD (Filed by)
Form SC 13G/A
01/25/2019
3:33 PM
Intec Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2019
3:16 PM
GENDREAU R MICHAEL (Reporting)
Intec Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:14 PM
Intec Pharma (Issuer)
Linscott Walt Addison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:12 PM
Intec Pharma (Issuer)
Navon Nadav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:11 PM
Intec Pharma (Issuer)
Sassi Nir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.